You are viewing: France Single-use Bioprocessing Market analysis

The France Single-use Bioprocessing Market was valued at $255.7 Million in 2025 and projected to reach to $406.8 Million by 2030, representing a compound annual growth rate of 9.7%. France's single-use bioprocessing market is poised for sustained growth, driven by the country's strategic focus on biopharmaceutical manufacturing and CDMO capabilities.

France Single-use Bioprocessing Market Trends and Insights

  • This 9.7% compound annual growth rate reflects France's strengthening position in biopharmaceutical manufacturing and contract development and manufacturing organization (CDMO) services.
  • France's investment in advanced bioprocessing infrastructure and regulatory support for innovative therapies is driving adoption of single-use technologies across the country's pharmaceutical and biotechnology sectors. The French market benefits from a robust healthcare ecosystem, established pharmaceutical manufacturing capabilities, and proximity to major European biotech hubs.
  • France's commitment to reducing manufacturing costs and improving operational flexibility has accelerated the transition from traditional stainless-steel systems to single-use bioprocessing solutions.
  • Between 2025 and 2030, France is expected to see increased demand from both established pharmaceutical companies and emerging biotech firms seeking scalable, cost-effective production methods..

Key Market Statistics

  • CAGR (2025-2030) 9.7% CAGR
  • Market Size, 2025 ~USD 255.7 Million
  • Forecast, 2030 ~USD 406.8 Million
  • Country France

France Single-use Bioprocessing Market Overview

Market Valuation Growth :

France's single-use bioprocessing market is valued at USD 255.7 million in 2025, with projections reaching USD 406.8 million by 2030, representing a robust 9.7% CAGR over the forecast period.

CDMO Sector Expansion :

France is strengthening its position as a key hub for contract development and manufacturing organization (CDMO) services, driven by increasing demand for flexible, cost-effective biopharmaceutical production solutions.

Infrastructure Investment :

Significant investment in advanced bioprocessing infrastructure across France is supporting the adoption of single-use technologies, reducing capital expenditure and accelerating time-to-market for biopharmaceutical companies.

Regulatory Support :

France's alignment with EU regulatory frameworks and strong life sciences ecosystem provides a competitive advantage for bioprocessing innovation and manufacturing excellence in the region.

France Single-use Bioprocessing Market Dynamics

  • The 9.7% CAGR reflects increasing adoption of single-use technologies among French biotech companies and contract manufacturers seeking operational flexibility and reduced contamination risks.
  • Investment in state-of-the-art facilities and skilled workforce development continues to position France as a preferred destination for bioprocessing operations in Europe. The forecast expansion to USD 406.8 million by 2030 underscores growing demand for personalized medicine, cell and gene therapy manufacturing, and vaccine production.
  • France's proximity to major European markets, combined with its robust regulatory environment and innovation ecosystem, supports long-term market growth.
  • Strategic partnerships between academic institutions, government bodies, and private sector players are expected to accelerate technology adoption and market penetration throughout the forecast period..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • France's single-use bioprocessing market is valued at USD 255.7 million in 2025 and will reach USD 406.8 million by 2030, growing at a 9.7% CAGR.
    • France's established pharmaceutical manufacturing base and CDMO sector are primary drivers of single-use technology adoption.
    • France's regulatory environment and healthcare infrastructure support the transition to flexible, cost-effective bioprocessing solutions.
    • Between 2025 and 2030, France will see increased investment from both multinational pharma and emerging biotech companies in single-use systems.

    Single-use Bioprocessing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONSUMABLES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 13.3% from 2025 to 2030
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 18.03 (2025)
    Revenue Forecast (Billions) ~USD 33.67 (2030)
    Segments Covered Product, Type, Scale Range, Scale

    France Single-use Bioprocessing Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Equipment

    By Type

    • 2D Bags & Containers
    • 3D Bags & Containers
    • Bag Assemblies
    • Bottle Assemblies
    • Filtration Assemblies
    • Mixing System Assemblies
    • Other Assemblies
    • Other Single-Use Consumables
    • Other Single-Use Equipment
    • Single-Use Assemblies
    • Single-Use Bags & Containers
    • Single-Use Bioreactors
    • Single-Use Chromatography Columns
    • Single-Use Chromatography Systems
    • Single-Use Filters
    • Single-Use Filtration Systems
    • Single-Use Mixing Systems
    • Single-Use Sensors

    By Scale Range

    • 101–500 L Bioreactors
    • 11–100 L Bioreactors
    • 501–1,500 L Bioreactors
    • >1,500 L Bioreactors
    • =10 L Bioreactors

    By Scale

    • Manufacturing-Scale Filtration Systems
    • Manufacturing-Scale Mixing Systems
    • Pilot-Scale Filtration Systems
    • Pilot-Scale Mixing Systems
    • R&D-Scale Filtration Systems
    • R&D-Scale Mixing Systems

    Target Audience

    • Biopharmaceutical Manufacturers : French and European biotech companies need France-specific market data to evaluate single-use bioprocessing adoption, assess manufacturing capacity requirements, and identify CDMO partnerships within the country.
    • CDMO Service Providers : Contract manufacturers and service providers require detailed France market insights to benchmark competitive positioning, identify growth opportunities, and develop service offerings aligned with local demand trends.
    • Equipment & Technology Suppliers : Bioprocessing equipment manufacturers need France market analysis to understand adoption rates, customer segments, and infrastructure investment trends to optimize sales strategies and product development for the French market.
    • Investment & Private Equity Firms : Investors evaluating bioprocessing opportunities in France require market-specific data on valuation, growth projections, and sector dynamics to make informed investment decisions and identify acquisition targets.
    • Government & Policy Organizations : French regulatory bodies and economic development agencies need market intelligence to inform bioprocessing policy, infrastructure planning, and incentive programs supporting the country's biopharmaceutical sector growth.

    Key Companies in the France Single-use Bioprocessing Market

    CompanyHQOwnershipStrongest segments

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for France (USD 255.7M in 2025) with verified 9.7% CAGR projections through 2030, enabling accurate business planning and investment decisions specific to the French market.
    • Competitive Landscape Intelligence : Understand France's positioning within the European bioprocessing ecosystem, including CDMO capabilities, infrastructure investments, and competitive advantages that differentiate the French market from neighboring regions.
    • Regulatory & Infrastructure Insights : Access detailed analysis of France's regulatory environment, bioprocessing infrastructure development, and government support mechanisms that impact market dynamics and investment opportunities in the country.
    • Sector-Specific Growth Drivers : Identify key growth catalysts specific to France, including cell and gene therapy demand, vaccine manufacturing expansion, and CDMO service adoption among French and European biopharmaceutical companies.
    • Strategic Market Entry Planning : Leverage France-specific market data to develop targeted go-to-market strategies, partnership opportunities, and investment theses for bioprocessing companies seeking to establish or expand operations in France.

    Frequently asked questions

    What is the current market size of single-use bioprocessing in France?

    France's single-use bioprocessing market was valued at USD 255.7 million in 2025 and is expected to grow to USD 406.8 million by 2030.

    What is the growth rate for single-use bioprocessing in France?

    France's single-use bioprocessing market is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2025 to 2030.

    Why is France adopting single-use bioprocessing technologies?

    France is adopting single-use bioprocessing to reduce manufacturing costs, improve operational flexibility, and meet the growing demand for biopharmaceutical production from both established and emerging biotech companies.

    Which sectors in France are driving single-use bioprocessing demand?

    France's pharmaceutical manufacturing sector, contract development and manufacturing organizations (CDMOs), and emerging biotechnology companies are the primary drivers of single-use bioprocessing adoption.

    What market value is France expected to reach by 2030?

    France's single-use bioprocessing market is forecast to reach USD 406.8 million by 2030, representing significant growth from the 2025 baseline of USD 255.7 million.

    RESEARCH METHODOLOGY

    This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-use bioprocessing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioprocessing market. The secondary sources used for this study include the World Health Organization (WHO), the National Institutes of Health (NIH), the United States Food and Drug Administration (US FDA), the National Institute for Bioprocessing Research and Training (NIBRT), the Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), the European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), the National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, BioProcess International, Journal of Bioprocessing and Biotechni ques, BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After acquiring foundational knowledge about the global single-use bioprocessing market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & research institutes. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

    These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

    The following is a breakdown of the primary respondents:

    Single-use Bioprocessing Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    After arriving at the overall market size from the estimation process, the total market was split into several segments and subsegments.

    Single-use Bioprocessing Market

    Data Triangulation

    After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Single-use bioprocessing refers to the use of disposable, pre-sterilized equipment and consumables in the production of biopharmaceutical products. Single-use technologies (SUTs) include a range of products, such as bioreactors, mixers, filters, tubing, connectors, and storage bags, all designed for one-time use. Key benefits of single-use bioprocessing include reduced risk of cross-contamination, low capital and operational costs, faster turnaround times, and greater flexibility in manufacturing. These advantages make single-use systems particularly attractive to produce biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.

    Stakeholders

    • Single-use bioprocessing equipment and consumables manufacturing companies
    • Single-use bioprocessing equipment and consumables distributors
    • Pharmaceutical and biotechnology companies
    • Contract manufacturing companies (CMOs)
    • Contract research organizations (CROs)
    • Academic and research institutes
    • Life science companies
    • Market research and consulting firms
    • Venture capitalists and investors
    • Government organizations
    • Private research firms

    Report Objectives

    • To define, describe, and forecast the single-use bioprocessing market, by product, application, workflow, molecule type, and end user, in terms of value
    • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
    • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall single-use bioprocessing market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile key players in the single-use bioprocessing market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments in the single-use bioprocessing market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
    • To benchmark players within the single-use bioprocessing market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

     

    Get the Full Single-use Bioprocessing Market Report

    Full forecast, segment splits, and company analysis for all Single-use Bioprocessing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status